232 related articles for article (PubMed ID: 24825892)
1. Rhbdf2 mutations increase its protein stability and drive EGFR hyperactivation through enhanced secretion of amphiregulin.
Hosur V; Johnson KR; Burzenski LM; Stearns TM; Maser RS; Shultz LD
Proc Natl Acad Sci U S A; 2014 May; 111(21):E2200-9. PubMed ID: 24825892
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP
J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
4. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.
Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S
Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858
[TBL] [Abstract][Full Text] [Related]
6. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
Horiuchi K; Le Gall S; Schulte M; Yamaguchi T; Reiss K; Murphy G; Toyama Y; Hartmann D; Saftig P; Blobel CP
Mol Biol Cell; 2007 Jan; 18(1):176-88. PubMed ID: 17079736
[TBL] [Abstract][Full Text] [Related]
7. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
[TBL] [Abstract][Full Text] [Related]
8. Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice.
Siggs OM; Grieve A; Xu H; Bambrough P; Christova Y; Freeman M
Biol Open; 2014 Nov; 3(12):1151-7. PubMed ID: 25395669
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts.
Shiomi T; Boudreault F; Padem N; Higashiyama S; Drazen JM; Tschumperlin DJ
Wound Repair Regen; 2011; 19(2):229-40. PubMed ID: 21362091
[TBL] [Abstract][Full Text] [Related]
10. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
11. ADAM-mediated amphiregulin shedding and EGFR transactivation.
Kasina S; Scherle PA; Hall CL; Macoska JA
Cell Prolif; 2009 Dec; 42(6):799-812. PubMed ID: 19735466
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin exosomes increase cancer cell invasion.
Higginbotham JN; Demory Beckler M; Gephart JD; Franklin JL; Bogatcheva G; Kremers GJ; Piston DW; Ayers GD; McConnell RE; Tyska MJ; Coffey RJ
Curr Biol; 2011 May; 21(9):779-86. PubMed ID: 21514161
[TBL] [Abstract][Full Text] [Related]
13. Pathological mutations reveal the key role of the cytosolic iRhom2 N-terminus for phosphorylation-independent 14-3-3 interaction and ADAM17 binding, stability, and activity.
Bläsius K; Ludwig L; Knapp S; Flaßhove C; Sonnabend F; Keller D; Tacken N; Gao X; Kahveci-Türköz S; Grannemann C; Babendreyer A; Adrain C; Huth S; Baron JM; Ludwig A; Düsterhöft S
Cell Mol Life Sci; 2024 Feb; 81(1):102. PubMed ID: 38409522
[TBL] [Abstract][Full Text] [Related]
14. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
[TBL] [Abstract][Full Text] [Related]
15. iRhom2 promotes lupus nephritis through TNF-α and EGFR signaling.
Qing X; Chinenov Y; Redecha P; Madaio M; Roelofs JJ; Farber G; Issuree PD; Donlin L; Mcllwain DR; Mak TW; Blobel CP; Salmon JE
J Clin Invest; 2018 Apr; 128(4):1397-1412. PubMed ID: 29369823
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
[TBL] [Abstract][Full Text] [Related]
18. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
Breshears LM; Schlievert PM; Peterson ML
J Biol Chem; 2012 Sep; 287(39):32578-87. PubMed ID: 22833676
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
